Background Tamoxifen has been US Food and Drug Administration approved for primary prevention of breast cancer since 1998 but has not been widely adopted, in part because of increased risk of serious side effects

مهمان عزیز شما حق دیدن لینک ها را ندارید برای استفاده از امکانات کامل انجمن عضو شوید

عضویت